Apr 02 2025 9 mins
Visit https://www.peervoice.com/YCX860 to view the entire programme with slides. After completing “Alon Altman, MD, FRCSC, CCPE - It Takes Two: Integrating Immunotherapy in Combination With Chemotherapy Into Recurrent or Primary Advanced Endometrial Cancer Care”, participants will be able to: Discuss current unmet needs in the frontline management of advanced endometrial cancer and the rationale for immunotherapy-chemotherapy combinations in this setting; Evaluate the clinical data for immunotherapy plus chemotherapy combinations for recurrent or primary advanced endometrial cancer; and Outline how to individualize treatment selection and manage safety concerns with available combination regimens to optimize patient outcomes.